A new generation XIAP inhibitor induces apoptosis of human myeloma cells and synergises with conventional and novel anti-myeloma therapeutics

被引：0
|
作者：
Khong, Tiffany [1 ]
Spencer, Andrew [1 ]
机构：
[1] Alfred Hosp, Myeloma Res Grp, Melbourne, Vic, Australia
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4787.4787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4787
引用
收藏
页码：270B / 270B
页数：1
相关论文
共 50 条
  • [21] Homoharringtonine induces apoptosis and growth arrest in human myeloma cells
    Lou, Yin-Jun
    Qian, Wen-Bin
    Jin, Jie
    LEUKEMIA & LYMPHOMA, 2007, 48 (07) : 1400 - 1406
  • [22] In Vitro Anti-Myeloma Activity of the Multitargeted Kinase Inhibitor Midostaurin in the Context of Heterotypic Cocultures of Myeloma Cells with Nonmalignant Microenvironmental Accessory Cells
    Lawasut, Panisinee
    Jacobs, Hannah M.
    Delmore, Jake E.
    Negri, Joseph
    McMillin, Douglas W.
    Weisberg, Ellen L.
    Griffin, James D.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    BLOOD, 2011, 118 (21) : 1260 - 1260
  • [23] New tubulin polymerization inhibitor derived from thalidomide: Implications for anti-myeloma therapy
    Kizaki, Masahiro
    Hashimoto, Yuichi
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (08) : 754 - 765
  • [24] Cord Blood Regulatory T Cells Do Not Impair Anti-Myeloma Effect of Conventional T Cells
    Nishimoto, Mitsutaka
    Zeng, Ke
    Huang, Meixian
    Lyu, Mi-Ae
    Shah, Nina
    Iyer, Swaminathan P.
    Orlowski, Robert Z.
    Parmar, Simrit
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S225 - S225
  • [25] Significant in-vitro anti-myeloma activity of a novel Akt inhibitor MK2206
    Ramakrishnan, Vijay
    Haug, Jessica
    Kimlinger, Teresa
    Hailing, Timothy
    Wellik, Linda
    Rajkumar, S. Vincent
    Kumar, Shaji
    CANCER RESEARCH, 2010, 70
  • [26] Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma
    Cheevapruk, Kodcharat
    Ueno, Mikinori
    Sungwan, Prin
    Sittithumcharee, Gunya
    Kariya, Ryusho
    Sampattavanich, Somponnat
    Okada, Seiji
    ANTICANCER RESEARCH, 2024, 44 (03) : 1023 - 1031
  • [27] Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
    Leivas, Alejandra
    Perez-Martinez, Antonio
    Jesus Blanchard, Maria
    Martin-Clavero, Estela
    Fernandez, Lucia
    Jose Lahuerta, Juan
    Martinez-Lopez, Joaquin
    ONCOIMMUNOLOGY, 2016, 5 (12):
  • [28] Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells
    Stefka, A. T.
    Park, J-H
    Matsuo, Y.
    Chung, S.
    Nakamura, Y.
    Jakubowiak, A. J.
    Rosebeck, S.
    BLOOD CANCER JOURNAL, 2016, 6 : e460 - e460
  • [29] A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells
    Takeshi Kawano
    Naoki Agata
    Surender Kharbanda
    David Avigan
    Donald Kufe
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 329 - 335
  • [30] A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells
    Kawano, Takeshi
    Agata, Naoki
    Kharbanda, Surender
    Avigan, David
    Kufe, Donald
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) : 329 - 335
12345